Announced Wed, 24 Jun · 18:54 IST
Board meeting on 2 July to consider fundraise; trading window closed
Compliance View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve
Awaiting price reaction for this filing.
AI summary
Asston Pharmaceuticals has informed BSE that its board will meet on Thursday, 2 July 2026, to consider raising funds through any permitted method, including a preferential issue, subject to shareholder and regulatory approvals. The trading window for dealing in company securities is closed from 24 June to 4 July 2026 for all connected and designated persons under the insider trading code. BSE Code 544445.
Likely market impact
Signals possible equity dilution via preferential issue; insiders barred from trading until 4 July. Watch for fundraising terms post-board meeting.